Amixetrine
![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
24622-72-8 ![]() |
PubChem (CID) | 71911 |
ChemSpider |
64922 ![]() |
UNII |
7UL287YTPJ ![]() |
ChEMBL |
CHEMBL2104080 ![]() |
Chemical and physical data | |
Formula | C17H27NO |
Molar mass | 261.40 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Amixetrine (INN) (brand name Somagest; developmental code name CERM-898) is a drug that was formerly marketed in France but is now no longer sold.[1][2] According to various sources it has been said to be an anti-inflammatory, antidepressant, antispasmodic, anticholinergic, antihistamine, and antiserotonergic, but its definitive indications and pharmacology are unclear.[1][2] The drug was first synthesized in 1969 and was introduced in France in 1972.[1][2]
References
- 1 2 3 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 80–. ISBN 978-1-4757-2085-3.
- 1 2 3 William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 285–. ISBN 978-0-8155-1856-3.
This article is issued from Wikipedia - version of the 9/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.